4.7 Review

Protein kinase C alpha: disease regulator and therapeutic target

Journal

TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 31, Issue 1, Pages 8-14

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2009.10.006

Keywords

-

Funding

  1. British Heart Foundation [RG/05/015, PG/07/118/24152]

Ask authors/readers for more resources

Protein kinase C alpha (PKC alpha) is a member of the AGC (which includes PKD, PKG and PKC) family of serine/threonine protein kinases that is widely expressed in mammalian tissues. It is closely related in structure, function and regulation to other members of the protein kinase C family, but has specific functions within the tissues in which it is expressed. There is substantial recent evidence, from gene knockout studies in particular, that PKC alpha activity regulates cardiac contractility, atherogenesis, cancer and arterial thrombosis. Selective targeting of PKC alpha therefore has potential therapeutic value in a wide variety of disease states, although will be technically complicated by the ubiquitous expression and multiple functions of the molecule.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available